Literature DB >> 6952778

Monoclonal antimacrophage antibodies: human pulmonary macrophages express HLA-DR (Ia-like) antigens in culture.

R Mason, J Austyn, F Brodsky, S Gordon.   

Abstract

Study of human macrophages and their role in disease has been hampered by lack of well-characterized tissue macrophages. We describe a simple procedure to obtain viable adherent cells in good yield from resected lung, characterize the cells as greater than 95% macrophage by standard criteria, and document expression of marker properties previously described in rodent macrophages. Human pulmonary macrophages were used to produce monoclonal antibodies and to study expression of HLA-A,B,C, HLA-DR, and related antigens. A new monoclonal mouse antibody, 18, showed restricted binding to macrophages from human lung or blood and to B lymphoid cells, but did not bind to closely related cells. With antibody 18 and other monoclonal antibodies of known specificity, DA2 and Genox 3.53, we showed that a remarkably high proportion of human pulmonary macrophages express HLA-DR framework and DC1 polymorphic determinants in culture. Although the macrophages differed in source and in their state of activation, single cell analysis revealed no heterogeneity in antigen expression.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6952778     DOI: 10.1164/arrd.1982.125.5.586

Source DB:  PubMed          Journal:  Am Rev Respir Dis        ISSN: 0003-0805


  10 in total

1.  Functional characteristics of human alveolar macrophages in lung cancer.

Authors:  N Clerici; F Leyva-Cobián; S Reboiras; P Lázaro de Mercado
Journal:  Lung       Date:  1986       Impact factor: 2.584

2.  Human macrophage activation. Modulation of mannosyl, fucosyl receptor activity in vitro by lymphokines, gamma and alpha interferons, and dexamethasone.

Authors:  T Mokoena; S Gordon
Journal:  J Clin Invest       Date:  1985-02       Impact factor: 14.808

3.  Monoclonal antibody EBM/11: high cellular specificity for human macrophages.

Authors:  P M Kelly; E Bliss; J A Morton; J Burns; J O McGee
Journal:  J Clin Pathol       Date:  1988-05       Impact factor: 3.411

Review 4.  Immunopathogenesis in tuberculosis, Part I: Cellular mechanisms of resistance.

Authors:  V Seth; U Singh
Journal:  Indian J Pediatr       Date:  1987 May-Jun       Impact factor: 1.967

Review 5.  Bronchoalveolar T lymphocytes and pulmonary sarcoidosis.

Authors:  G W Hunninghake
Journal:  Clin Rev Allergy       Date:  1985-05

6.  Isolation and partial characterization of a human alveolar macrophage-derived neutrophil-activating factor.

Authors:  J E Pennington; T H Rossing; L W Boerth; T H Lee
Journal:  J Clin Invest       Date:  1985-04       Impact factor: 14.808

7.  Expression of the CD11/CD18 cell surface adhesion glycoprotein family and MHC class II antigen on blood monocytes and alveolar macrophages in interstitial lung diseases.

Authors:  H C Hoogsteden; P T van Hal; J M Wijkhuijs; W Hop; C Hilvering
Journal:  Lung       Date:  1992       Impact factor: 2.584

8.  Delineation of pulmonary alveolar macrophage subpopulations by flow cytometry in normal subjects and in patients with lung cancer.

Authors:  C F McDonald; P Hutchinson; R C Atkins
Journal:  Clin Exp Immunol       Date:  1993-01       Impact factor: 4.330

9.  Human bronchoalveolar macrophage heterogeneity demonstrated by histochemistry, surface markers and phagocytosis.

Authors:  V A Gant; A S Hamblin
Journal:  Clin Exp Immunol       Date:  1985-06       Impact factor: 4.330

10.  Degradation of fibrin and elastin by intact human alveolar macrophages in vitro. Characterization of a plasminogen activator and its role in matrix degradation.

Authors:  H A Chapman; O L Stone; Z Vavrin
Journal:  J Clin Invest       Date:  1984-03       Impact factor: 14.808

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.